Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study

Metabolism. 2012 Dec;61(12):1747-55. doi: 10.1016/j.metabol.2012.05.006. Epub 2012 May 30.

Abstract

Objective: Little is known about serum uric acid (SUA) role for hypertension in the Asian countries with low cardiovascular events. We aimed to explore the relationship in a comprehensive Chinese cohort.

Methods: Participants in the Taiwanese Survey on Prevalences of Hypertension, Hyperglycemia, and Hyperlipidemia (TwSHHH) who were free of hypertension at baseline recruitment in 2002 (n=3257) were evaluated for the longitudinal association between baseline SUA and blood pressure progression (BPP) and incident hypertension.

Results: During a mean follow-up of 5.41 years, 1119 persons (34.3%) had experienced progression to a higher blood pressure stage and 496 persons (15.2%) had developed hypertension. In multivariate analyses, the adjusted hazard ratios (HRs) [95% confidence intervals (CIs)] comparing the highest and lowest SUA quartiles were 1.78 (1.11-2.02, P for trend .004) for BPP and 1.68 (1.23-2.04, P for trend .028) for incident hypertension. The positively graded relationships between SUA concentration and blood pressure outcomes were observed in both males and females. More interestingly, a statistically significant trend for increasing risk of BPP and incident hypertension across SUA quartiles was most pronounced in participants with abdominal obesity.

Conclusion: We concluded that SUA level was an independent predictor of blood pressure progression and incident hypertension in a Chinese population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People / statistics & numerical data*
  • Biomarkers / blood
  • Blood Pressure*
  • Cohort Studies
  • Disease Progression
  • Female
  • Humans
  • Hypertension / blood*
  • Hypertension / physiopathology*
  • Incidence
  • Male
  • Middle Aged
  • Obesity, Abdominal / blood*
  • Obesity, Abdominal / physiopathology*
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Taiwan / epidemiology
  • Uric Acid / blood*

Substances

  • Biomarkers
  • Uric Acid